Expressions and significance of uPA and V-ATPase mRNA in hepatocellular carcinoma

Chinese-German Journal of Clinical Oncology

Volumn 7, Issue 11, 2008, Pages 631-634

  Liao, Zhiling ^a   Lin, Jing ^a   Luo, Dianzhong ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma (HCC); uPAmRNA; V ATPasem RNA

Indexed keywords

EID: 56449086769     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/s10330-008-0100-5     Document Type: Article

References (6)

1. Choong PF, Nadesapillai AP. Urokinase plasminogen activator system: A multifunctional role in tumor progress and metastasis. Clin Orthop Relat Res, 2003, 415: 46-58.
2. Racker E. Why do cancers have high aembic glycolysis? J Cell Physiol, 1976, 89: 697-700.
3. Rao JS. Molecular mechanisms of glioma invasiveness: The role of proteases. Nat Rev Cancer, 2003, 3: 489-501.
4. Kaneko T, Konno H, Baba M. et al. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. Cancer Sci, 2003, 94: 43-49.
5. Nishi T, Forgac M. The vacuolar (H+)-ATPases nature's most versatile proton pumps. Nat Rev Mol Cell Biol, 2002, 3: 94-103.
6. Sennoune SR, Bakunts K, Martinez GM, et al. Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: Distribution and functional activity. Am J Physiol Cell Physiol, 2004, 268: 1443-1452.